# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008259
Filing Date
2022-03-31
Accepted
2022-03-31 07:54:51
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2065825
2 |  | ex10-6.htm | EX-10.6 | 127370
3 |  | ex10-11.htm | EX-10.11 | 115234
4 |  | ex10-14.htm | EX-10.14 | 61988
5 |  | ex21.htm | EX-21 | 3281
6 |  | ex23-1.htm | EX-23.1 | 3426
7 |  | ex31-1.htm | EX-31.1 | 15740
8 |  | ex31-2.htm | EX-31.2 | 15712
9 |  | ex32.htm | EX-32 | 12608
10 |  | form10-k_001.jpg | GRAPHIC | 89875
11 |  | ex10-6_001.gif | GRAPHIC | 12358
12 |  | ex10-6_002.jpg | GRAPHIC | 22016
13 |  | ex10-11logo_001.jpg | GRAPHIC | 16638
14 |  | ex10-11_001.jpg | GRAPHIC | 16096
| Complete submission text file | 0001493152-22-008259.txt |  | 8194019

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | abeo-20211231.xsd | EX-101.SCH | 46154
16 | INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | abeo-20211231_cal.xml | EX-101.CAL | 75242
17 | INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | abeo-20211231_def.xml | EX-101.DEF | 207007
18 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | abeo-20211231_lab.xml | EX-101.LAB | 403202
19 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | abeo-20211231_pre.xml | EX-101.PRE | 328737
82 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1096362

Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 22789172
SIC: 2834 Pharmaceutical Preparations